A comprehensive review of quantum bioreactor cell manufacture: Research and clinical applications

• Published in: Cytotherapy (Oxford, England) Vol. 25; no. 10; pp. 1017 - 1026
• Main Authors: Hulme, Charlotte H., Mennan, Claire, McCarthy, Helen S., Davies, Rebecca, Lan, Tian, Rix, Larissa, Perry, Jade, Wright, Karina
• Format: Journal Article
• Language: English
• Published: England Elsevier Inc 01-10-2023
• Subjects: bioreactor; Bioreactors; Cell Culture Techniques - methods; Cell Proliferation; cell therapy; Cell- and Tissue-Based Therapy; extracellular vesicles; Good Manufacturing Practice; Mesenchymal Stem Cells; Quantum; up-scale manufacture; up-scale manufacture; Quantum; extracellular vesicles; bioreactor; cell therapy; Good Manufacturing Practice
• ISSN: 1465-3249; 1477-2566
• DOI: 10.1016/j.jcyt.2023.04.004

The Quantum cell expansion system manufactured by Terumo-BCT is perhaps the most widely reported Good Manufacturing Practice–compliant bioreactor used for the expansion of adherent cell populations, both for research purposes and clinical cell–based therapies/trials. Although the system was originally designed for adherent cell expansion, more recently suspension cultures and extracellular vesicle manufacturing protocols have been published using the Quantum system. Cell therapy research and regenerative medicine in general is a rapidly expanding field and as such it is likely that the use of this system will become even more widespread and perhaps mandatory, for both research and development and in the clinic. The purpose of this review is to describe, compare and discuss the diverse range of research and clinical applications currently using the Quantum system, which to our knowledge has not previously been reviewed. In addition, current and future challenges will also be discussed.